Molecular Pathways Associated with Ibrutinib Resistance in Mantle Cell Lymphoma

被引：0
作者：
Zhang, Liang
Nomie, Krystle
Zhang, Shaojun
Liu, Yang
Guo, Hui
Huang, Shengjian
Wang, Jeffrey
Lopez, Elyse
Zhang, Hui
Lorence, Elizabeth A.
Merolle, Maria
Balaji, Swathi
Ahmed, Makhdum
Jiang, Changying
Wang, Linghua
Wang, Michael
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2738
引用
收藏
页数：1
相关论文
共 50 条
[41]   Ibrutinib in Mantle Cell Lymphoma Patients: Analysis of the Czech Lymphoma Study Group [J].
Obr, Ales ;
Klener, Pavel, Jr. ;
Janikova, Andrea ;
Mocikova, Heidi ;
Belada, David ;
Salek, David ;
Jirkuvova, Andrea ;
Papajik, Tomas ;
Trneny, Marek .
BLOOD, 2021, 138
[42]   Ibrutinib in refractory mantle cell lymphoma or relapsed data update [J].
Paillassa, Jerome .
HEMATOLOGIE, 2015, 21 (05) :257-259
[43]   Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma [J].
Tam, Constantine S. ;
Anderson, Mary Ann ;
Pott, Christiane ;
Agarwal, Rishu ;
Handunnetti, Sasanka ;
Hicks, Rodney J. ;
Burbury, Kate ;
Turner, Gillian ;
Di Iulio, Juliana ;
Bressel, Mathias ;
Westerman, David ;
Lade, Stephen ;
Dreyling, Martin ;
Dawson, Sarah-Jane ;
Dawson, Mark A. ;
Seymour, John F. ;
Roberts, Andrew W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) :1211-1223
[44]   Ibrutinib-associated tumor lysis syndrome in a patient with mantle cell lymphoma: A case report [J].
Kaur, Varinder ;
Swami, Arjun .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (03) :235-239
[45]   Molecular Profiling plus In Vitro and In Vivo Drug Efficacy Analyses Identifies Novel Treatments to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma [J].
Liu, Yang ;
Nomie, Krystle ;
Jiang, Changying ;
Yao, Yixin ;
Zhang, Liang ;
Wang, Michael .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 :S318-S318
[46]   Multi-omics analysis of mantle cell lymphoma reveals an immune-cold tumor microenvironment associated with ibrutinib resistance. [J].
Nomie, Krystle ;
Jain, Preetesh ;
Kotlov, Nikita ;
Segodin, Vitaly ;
Cai, Qingsong ;
Liu, Yang ;
Navsaria, Lucy ;
Svekolkin, Viktor ;
Bagaev, Alexander ;
Frenkel, Felix ;
Ataullakhanov, Ravshan ;
Fowler, Nathan Hale ;
Wang, Michael .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[47]   CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma [J].
Mohanty, Atish ;
Sandoval, Natalie ;
Das, Manasi ;
Pillai, Raju ;
Chen, Lu ;
Chen, Robert W. ;
Amin, Hesham M. ;
Wang, Michael ;
Marcucci, Guido ;
Weisenburger, Dennis D. ;
Rosen, Steven T. ;
Pham, Lan V. ;
Ngo, Vu N. .
ONCOTARGET, 2016, 7 (45) :73558-73572
[48]   Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma [J].
Hoang, Nguyet-Minh ;
Liu, Yunxia ;
Bates, Paul D. ;
Heaton, Alexa R. ;
Lopez, Angelica F. ;
Liu, Peng ;
Zhu, Fen ;
Chen, Ruoyu ;
Kondapelli, Apoorv ;
Zhang, Xiyu ;
Selberg, Paul E. ;
Ngo, Vu N. ;
Skala, Melissa C. ;
Capitini, Christian M. ;
Rui, Lixin .
CELL REPORTS MEDICINE, 2024, 5 (04)
[49]   CCND1 Mutations Increase Protein Stability and Promote Ibrutinib Resistance in Mantle Cell Lymphoma [J].
Mohanty, Atish Ranjan ;
Sandoval, Natalie ;
Das, Manasi ;
Amin, Hesham M. ;
Marcucci, Guido ;
Pillai, Raju ;
Weisenburger, Dennis D. ;
Rosen, Steven T. ;
Lan Pham ;
Ngo, Vu N. .
BLOOD, 2016, 128 (22)
[50]   Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment [J].
Rudelius, Martina ;
Rosenfeldt, Mathias Tillmann ;
Leich, Ellen ;
Rauert-Wunderlich, Hilka ;
Solimando, Antonio Giovanni ;
Beilhack, Andreas ;
Ott, German ;
Rosenwald, Andreas .
HAEMATOLOGICA, 2018, 103 (01) :116-125
12345